Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunoprecise Antibodies Ltd

0.3849
-0.0201-4.96%
Post-market: 0.3600-0.0249-6.47%19:59 EDT
Volume:1.85M
Turnover:711.10K
Market Cap:17.61M
PE:-0.52
High:0.4050
Open:0.3959
Low:0.3602
Close:0.4050
Loading ...

Apple axes data protection tool after government security row

cityam
·
22 Feb

Institutional Property Advisors Advises Rockpoint and The Related Group in $131 Million Multifamily Asset Sale in North Phoenix

Business Wire
·
11 Feb

QuickLogic Unveils Aurora 2.9: Enhanced Performance and Seamless Integration

PR Newswire
·
10 Feb

Marcus & Millichap’s IPA Capital Markets Facilitates $165.9 Million Multifamily Financing in Northern Virginia

Business Wire
·
05 Feb

Exxon CEO Darren Woods: Hydrogen Incentives ‘Critical’ for Now

Hart Energy
·
04 Feb

Marcus & Millichap’s IPA Capital Markets Secures $79 Million Construction Loan for Transformation of Iconic San Antonio Landmark

Business Wire
·
28 Jan

Immunoprecise Antibodies Ltd - Atm Program Raises $7 Million in Gross Proceeds

THOMSON REUTERS
·
27 Jan

Immunoprecise Antibodies (Ipa) Announces Completion of at-the-Market Equity Offering and Full Conversion of Yorkville Debenture

THOMSON REUTERS
·
27 Jan

ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture

Business Wire
·
27 Jan

ImmunoPrecise Antibodies develops new class of GLP-1 therapies through AI

TipRanks
·
23 Jan

Top Midday Gainers

MT Newswires Live
·
23 Jan

BUZZ-ImmunoPrecise Antibodies jumps on AI-powered diabetes treatment

Reuters
·
23 Jan

US Stocks Higher; Netflix Profit Beats Estimates

Benzinga
·
22 Jan

ImmunoPrecise Antibodies Says New Class of GLP-1 Therapies Developed Using AI; Shares Jump

MT Newswires Live
·
22 Jan

Immunoprecise Antibodies Ltd - Has Developed a New Class of Glp-1 Therapies Entirely Through Artificial Intelligence

THOMSON REUTERS
·
22 Jan

IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes Treatment

Business Wire
·
22 Jan